WW International, Inc. (NASDAQ:WW) shares jumped more than 79% on Tuesday (fell 21% the next day) after the company reported its Q4 results, provided guidance for Q1 and most importantly announced plans to acquire Sequence (transaction valued at $132 million), a subscription telehealth platform offering access to healthcare providers specializing in chronic weight management.

Q4 EPS came in at ($0.46), worse than the Street estimate of $0.01. Revenue was $223.92 million, compared to the Street estimate of $224.32 million.

For Q1/23, the company expects revenue of $235 million, compared to the Street estimate of $243.8 million.

Management pointed out that while subscriber counts and growth at the company remain muted, better analytics and more thoughtful marketing are helping the company to attract and signup members, which appear stickier and hence lend to stronger longer-term economics.